Vaginal dryness in menopause: what it is, why it gets worse, and what actually works
The short answer
Vaginal dryness after menopause is usually part of genitourinary syndrome of menopause (GSM), caused by lower estrogen thinning the tissues of the vagina, vulva and bladder. Unlike hot flashes, it tends to get worse over time without treatment. Moisturizers and lubricants are the first step, and low-dose vaginal estrogen and other prescription options work well for many women, so ask your clinician.
Let's just say it: sex that used to feel fine now feels like sandpaper, your underwear seems to irritate you, and you might be running to the bathroom more than you'd like. Many of us quietly put up with this for years because nobody told us it has a name, a cause and good treatments. It does. Here is what we wish someone had told us sooner.
What is genitourinary syndrome of menopause?
Genitourinary syndrome of menopause, or GSM, is the medical name for what used to be called vaginal atrophy. The newer name is more honest, because the changes affect the vulva, vagina, urethra and bladder together. The Menopause Society's 2020 position statement estimates that GSM affects roughly 27% to 84% of postmenopausal women, and calls it underdiagnosed and undertreated.
The cause is lower estrogen. As Mayo Clinic explains, less estrogen leaves vaginal tissue thinner, drier, less elastic and more fragile. Menopause is the usual trigger, but the years leading up to it, surgical removal of both ovaries, breastfeeding, some cancer treatments and hormonal breast cancer therapy can do it too. Smoking is a risk factor, because it reduces blood flow and blunts the effect of the estrogen you still make.
Common symptoms
- Vaginal dryness, burning or itching
- Pain during sex, or light bleeding afterward
- Thin, watery or unusual discharge
- Burning with urination, urgency or needing to go more often
- More frequent urinary tract or vaginal infections
- Leaking urine
If the bladder side of this sounds familiar, we go deeper in frequent UTIs and bladder urgency after menopause.
Why it doesn't just go away
Hot flashes often fade with time. GSM usually doesn't. The 2020 position statement describes it as generally progressive without effective therapy. That is why waiting it out rarely works, and why it is worth bringing up even if your clinician doesn't ask. You are not being dramatic, and you are not alone.
Your treatment options, from simplest to prescription
| Option | What it does | Good to know |
|---|---|---|
| Vaginal moisturizers | Used regularly, they restore some moisture and last longer than lubricants | No prescription needed; a first step for milder symptoms |
| Lubricants | Reduce friction and pain during sex | Water or silicone based; oil-based products can damage latex condoms |
| Low-dose vaginal estrogen | Restores the tissue locally; comes as cream, tablet, insert or ring | Much less reaches the bloodstream than with oral estrogen |
| Vaginal DHEA (prasterone) | Nightly insert that the body converts into hormones including estrogen | Prescription |
| Ospemifene | A daily pill for moderate to severe painful sex | Prescription, nonestrogen |
| Systemic hormone therapy | Pills, patches or gel that treat the whole body | May make sense if you also have bothersome hot flashes |
| Pelvic floor physical therapy and dilators | Help with tightness, narrowing and pain | Often combined with other treatments |
Start with moisturizers and lubricants
The Menopause Society lists nonhormone lubricants during sex and long-acting vaginal moisturizers used regularly as first-line options for less severe symptoms. Think of them as two different jobs: moisturizers are maintenance a few times a week, lubricants are for the moment. Mayo Clinic suggests skipping products with glycerin or warming ingredients.
Low-dose vaginal estrogen
For moderate or persistent symptoms, low-dose vaginal estrogen is one of the most studied options. Because it acts locally, much less estrogen reaches the bloodstream than with pills, and the different forms seem to work about equally well. Two points from the position statement are especially reassuring: a progestogen is not recommended alongside low-dose vaginal estrogen, and routine checks of the uterine lining are not recommended for women without symptoms. Clinicians may still monitor women at higher risk of endometrial cancer.
The labels are catching up, too. In November 2025 the FDA announced it would remove the broad boxed warnings about heart disease, breast cancer and dementia from menopausal hormone therapy, and the American Urological Association welcomed the change as applied to low-dose vaginal estrogen. In February 2026, the FDA approved the first updated labels, including one for a vaginal estrogen ring. We explain the full story in what changed with HRT labels.
Other prescription options
Vaginal DHEA inserts and the oral pill ospemifene are alternatives if estrogen isn't right for you or you'd rather try something else. The position statement notes that long-term studies on the endometrial safety of vaginal estrogen, vaginal DHEA and ospemifene are still lacking, which is one more reason to keep your clinician in the loop. Mayo Clinic also lists a numbing prescription gel applied before sex for pain at the opening of the vagina.
Pelvic floor therapy, dilators and staying active
Many women with GSM benefit from pelvic floor physical therapy, especially when pain or tightness is part of the picture. Dilators can gently stretch tissue that has narrowed. Mayo Clinic notes that regular sexual activity, with or without a partner, may help keep tissues healthy by increasing blood flow, though the position statement says clinical trials haven't proven this yet. Either way, there's no pressure: comfort first.
What about lasers?
You may see vaginal laser treatments advertised. The Menopause Society's position is that there are not enough placebo-controlled trials of energy-based treatments, including laser, to draw conclusions about whether they work or are safe.
If you've had breast cancer
You still deserve relief. Nonhormone moisturizers, lubricants and dilators are the usual starting point. If those aren't enough, Mayo Clinic notes that low-dose vaginal estrogen may be an option to discuss with your oncologist, while systemic estrogen generally isn't recommended, especially for hormone-sensitive cancers. The position statement says treatment should reflect your needs and your oncologist's recommendations.
When to call your clinician
- Any bleeding after menopause. If you haven't had a period for 12 months or more, any vaginal bleeding, even spotting or pink or brown discharge, should be checked.
- Unexplained spotting, or bleeding after sex.
- Unusual discharge, burning or soreness.
- Painful sex that doesn't improve with a moisturizer or lubricant.
- Burning with urination plus fever, chills, or back or side pain, which can signal a kidney infection.
Questions to ask your clinician
- Do my symptoms fit genitourinary syndrome of menopause, or could something else be going on?
- Would low-dose vaginal estrogen make sense for me? Which form would you suggest?
- If I'd rather avoid estrogen, are vaginal DHEA or ospemifene options for me?
- Could pelvic floor physical therapy help with the pain?
- How long until I should expect improvement, and when should we follow up?
- Given my history (breast cancer, blood clots, other medicines), what's safest for me?
Talking about this can feel awkward. Our doctor visit playbook has scripts that make it easier to say out loud.
Questions
Does vaginal dryness after menopause go away on its own?
Usually not. Unlike hot flashes, genitourinary syndrome of menopause is generally progressive without treatment, according to The Menopause Society. The good news is that moisturizers, lubricants and prescription options such as low-dose vaginal estrogen can help a lot.
Is vaginal estrogen the same as hormone therapy?
Not quite. Low-dose vaginal estrogen works locally, and much less reaches the bloodstream than with pills or patches. The Menopause Society does not recommend adding a progestogen to low-dose vaginal estrogen. Systemic hormone therapy treats the whole body and is used for symptoms like hot flashes.
What is the difference between a vaginal moisturizer and a lubricant?
A moisturizer is used regularly, a few times a week, to keep tissue more hydrated over time. A lubricant is used during sex to reduce friction and pain. Many women use both.
Can I use vaginal estrogen after breast cancer?
Sometimes. Nonhormone options come first. If they aren't enough, low-dose vaginal estrogen may be an option to discuss with your oncologist, especially depending on whether your cancer was hormone sensitive.
Do vaginal laser treatments work?
The Menopause Society says there are not enough placebo-controlled trials of laser and other energy-based treatments to know whether they work or are safe.
Get the whole picture in one place
The Sisu Season Guide: every symptom decoded, every option explained, and exactly what to say at your appointment. Instant download. $27 until November 15, $37 after. 30-day money-back guarantee.
Not ready? Start with the free Symptom Snapshot.
Keep reading
- Low libido in menopause: why your sex drive disappeared, and what can help
- Frequent UTIs and bladder urgency after menopause: why it happens and what helps
- Itchy skin in menopause: dryness, crawling sensations, and how to get relief
- Night sweats in perimenopause: why they happen, how to get relief, and when it's not menopause
- Early signs of perimenopause: can it really start in your 30s?
- How long does perimenopause last, and how long do the symptoms stick around?
Education and personal experience, not medical advice. Talk with your own clinician before making health decisions.
Sources
- The North American Menopause Society, The 2020 genitourinary syndrome of menopause position statement (full text via ISSWSH)
- NAMS releases the 2020 Genitourinary Syndrome of Menopause Position Statement (EurekAlert!, Aug 31, 2020)
- Mayo Clinic: Genitourinary syndrome of menopause (vaginal atrophy), symptoms and causes
- Mayo Clinic: Genitourinary syndrome of menopause (vaginal atrophy), diagnosis and treatment
- FDA: HHS advances women's health, removes misleading FDA warnings on hormone replacement therapy (Nov 10, 2025)
- FDA approves label changes for first batch of menopausal hormone therapy products (Urology Times, Feb 12, 2026)
- American Urological Association: FDA announces removal of black box warning on low dose vaginal estrogen
- NHS: Menopause symptoms